Tag: CABOMETYX

Home / CABOMETYX

Categories

Cabozantinib is FDA-approved for hepatocellular carcinoma

  On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular carcinoma (HCC) who have previously been treat...
cabometyx

Scan the code